Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Published: 22 April 2024| Version 2 | DOI: 10.17632/dxthnf38zx.2
Contributors:
, Michael E. Hodsdon, Ying Grace Li, Greg Anglin, Shweta Urva, Karen Schneck, Jennifer N. Bardos, Ricardo Fonseca Martins, Katelyn Brown, Boris Calderon

Description

Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Files

Categories

Immunogenicity, Clinical Trial Results

Funding

Eli Lilly and Company

Licence